TAK-438
Drug timelines are a Plus or Pro feature.
17 regulatory and trial events tracked for TAK-438, covering 2013-06-21 to 2023-09-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection [Phase 3]